Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06799481 · ClinicalTrials.gov registry record · NA
Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors
A NA study of Primary Brain Neoplasm and Cancer-related Cognitive Dysfunction, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 2
- Study locations
NCT06799481 is a NA study of Primary Brain Neoplasm and Cancer-related Cognitive Dysfunction that is actively recruiting participants, run by Emory University. The registered enrollment target is 60 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT06799481, a NA study of Primary Brain Neoplasm and Cancer-related Cognitive Dysfunction, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 2
- Study locations
Study Summary
This clinical trial evaluates the impact of a research intervention of virtually supervised exercise program (RISE) on cancer-related cognitive impairment (CRCI), physical activity in adolescent and young adult (AYA) brain tumor survivors. This clinical trial also evaluates the impact of RISE on the collection of microorganisms that exist in the intestines (gut microbiome). Up to 45% of AYA brain tumor survivors experience CRCI, including issues with attention and memory. CRCI can have a negative impact on education, independent living and can worsen long-term quality of life. Moderate-intensity levels of exercise, particularly aerobic and resistance training, have been shown to improve cognitive function. Additionally, exercise can change the composition and function of the gut microbiome, which may lead to improved cognitive function. Unfortunately, only about 50% of AYAs with cancer receive exercise information or meet the physical activity recommendations. Tailoring a virtually delivered exercise intervention to meet the unique needs of AYAs may improve access to exercise. Participating in the virtual home-based exercise intervention, RISE, may improve physical activity and cognitive impairment in AYA brain tumor survivors and may also help researchers understand the relationship of exercise on the gut microbiome and cognitive function.
Conditions Studied
Interventions
- OTHER Medical Device Usage and Evaluation
- BEHAVIORAL Behavioral Intervention
- PROCEDURE Follow-Up
- OTHER Internet-Based Intervention
- OTHER Aerobic Exercise
Study Locations (2)
Georgia
- Emory University Hospital - Atlanta
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-02-13 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06799481
The ClinicalTrials.gov registry entry for NCT06799481 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Primary Brain Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Medical Device Usage and Evaluation is the first listed.
NCT06799481 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Georgia, Texas.
Frequently Asked Questions
What is clinical trial NCT06799481 about?
NCT06799481 is a clinical study titled "Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors". This clinical trial evaluates the impact of a research intervention of virtually supervised exercise program (RISE) on cancer-related cognitive impairment (CRCI), physical activity in adolescent and young adult (AYA) brain tumor survivors. This clinical trial also evaluates the impact of RISE on the...
What is the current status of trial NCT06799481?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-02-13. Estimated completion is 2027-07-31.
What conditions does trial NCT06799481 study?
This clinical trial studies the following conditions: Primary Brain Neoplasm, Cancer-related Cognitive Dysfunction.
What interventions are being tested in trial NCT06799481?
The interventions under investigation include: Medical Device Usage and Evaluation (OTHER), Behavioral Intervention (BEHAVIORAL), Follow-Up (PROCEDURE), Internet-Based Intervention (OTHER), Aerobic Exercise (OTHER).
Who is sponsoring clinical trial NCT06799481?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06799481 being conducted?
This trial has 2 study locations across Georgia, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Brain Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.